![Daniel Curran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Curran
Direktor/Vorstandsmitglied bei
XILIO THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2026
Profil
Daniel Curran is Chief Executive Officer at Timberlyne Therapeutics, Inc. since 2025.
Serving as Independent Director at Xilio Therapeutics, Inc. since 2020.
Director at Catalyst Pharmaceuticals, Inc. since 2025.
Director at Stargazer Pharmaceuticals, Inc. since 2019.
Independent Director at ALX Oncology Holdings, Inc. since 2025.
Managing Partner at Mountainfield Venture Partners LLC since 2024.
Former Director at Tome Biosciences, Inc. in 2024.
Director at Oak Hill Bio Corp.
from 2022 to 2024.
Principal at DuPont Merck Pharmaceutical Co. Vice President-Business & Corporate Development at Millennium Pharmaceuticals, Inc. from 1999 to 2008.
Senior VP, Head-Rare Genetics & Hematology at Takeda Pharmaceutical Co., Ltd. from 2019 to 2023.
Education includes undergraduate degree from King's College (Pennsylvania), MBA from The Wharton School of the University of Pennsylvania, and doctorate from the University of Pennsylvania Medical Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
| 02.01.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
| 20.11.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Daniel Curran
| Unternehmen | Position | Beginn |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.12.2020 |
| CATALYST PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 04.08.2025 |
| ALX ONCOLOGY HOLDINGS INC. | Direktor/Vorstandsmitglied | 12.08.2025 |
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Direktor/Vorstandsmitglied | 01.01.2019 |
Ehemalige bekannte Positionen von Daniel Curran
| Unternehmen | Position | Ende |
|---|---|---|
Tome Biosciences, Inc.
 Tome Biosciences, Inc. BiotechnologyHealth Technology Provides genomic medicine insertion and technologies services | Direktor/Vorstandsmitglied | 01.11.2024 |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization that develops medicines | Direktor/Vorstandsmitglied | 01.03.2024 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01.12.2023 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01.01.2008 |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Corporate Officer/Principal | - |
Ausbildung von Daniel Curran
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Catalyst Pharmaceuticals, Inc.
 Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
King's College (Pennsylvania)
 King's College (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
 University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Stargazer Pharmaceuticals, Inc.
Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Tome Biosciences, Inc.
Tome Biosciences, Inc. BiotechnologyHealth Technology Provides genomic medicine insertion and technologies services | Health Technology |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization that develops medicines | Commercial Services |
